Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99292313 | 9929231 | 3 | F | 20140919 | 20140224 | 20141001 | EXP | 20140073 | LUITPOLD | 24.00 | YR | F | N | 0.00000 | 20140929 | N | OT | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99292313 | 9929231 | 1 | PS | FERINJECT | FERRIC CARBOXYMALTOSE | 1 | INTRAVENOUS DRIP | 500 MG, 2 IN 1 TOTAL, INTRAVENOUS DRIP | Y | D | 203565 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99292313 | 9929231 | 1 | Fatigue |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99292313 | 9929231 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99292313 | 9929231 | Asthenia | |
| 99292313 | 9929231 | Blood parathyroid hormone decreased | |
| 99292313 | 9929231 | Fatigue | |
| 99292313 | 9929231 | Hypocalcaemia | |
| 99292313 | 9929231 | Hypophosphataemia | |
| 99292313 | 9929231 | Muscular weakness | |
| 99292313 | 9929231 | Renal tubular disorder | |
| 99292313 | 9929231 | Urine phosphorus increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 99292313 | 9929231 | LIT |
| 99292313 | 9929231 | FGN |
| 99292313 | 9929231 | HP |
Therapies reported
| no results found |